Plasma levels of matrix metalloproteinase-2,-3,-10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

Stijn A. Peeters, Lian Engelen, Jacqueline Buijs, Nish Chaturvedi, John H. Fuller, Casper G. Schalkwijk, Coen D. Stehouwer*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Web of Science)
Original languageEnglish
Article number31
JournalCardiovascular Diabetology
Publication statusPublished - 10 Mar 2015


  • Type 1 diabetes
  • Matrix metalloproteinase
  • Tissue inhibitor of metalloproteinase
  • Cardiovascular disease
  • Albuminuria
  • Retinopathy

Cite this